Sunitinib in the Treatment of Renal Cell Carcinoma: An Update on Recent Evidence

Therapeutic Advances in Urology - United States
doi 10.1177/1756287217713902
Full Text
Abstract

Available in full text

Categories
Urology
Date
Authors
Publisher

SAGE Publications

Related search

Sunitinib in the Treatment of Metastatic Renal Cell Carcinoma

Therapeutic Advances in Urology
Urology
2016English

Hypertension as Predictor of Sunitinib Treatment Outcome in Metastatic Renal Cell Carcinoma

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
2011English

Pneumatosis Cystoides Intestinalis Linked to Sunitinib Treatment for Renal Cell Carcinoma

IJU Case Reports
2019English

Angiotensin Inhibitors as Treatment of Sunitinib/Pazopanib-Induced Hypertension in Metastatic Renal Cell Carcinoma

Clinical Genitourinary Cancer
OncologyUrology
2017English

Update on the Biology and Management of Renal Cell Carcinoma

Journal of Investigative Medicine
BiochemistryMedicineGeneticsMolecular Biology
2018English

Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma After Nephrectomy

New England Journal of Medicine
Medicine
2016English

Sunitinib Causes Macrocytosis in Patients With Advanced Renal Cell Carcinoma

Current Oncology
Oncology
2010English

A Rare Case of Sunitinib-Induced Rhabdomyolysis in Renal Cell Carcinoma

Case Reports in Oncological Medicine
Oncology
2018English

Pcn70 - Assessing the Budget Impact of Including Sunitinib for the Treatment of Metastatic Renal Cell Carcinoma in Argentina

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy